An open-label trial of risperidone long-acting injectable in the treatment of subject with recent onset psychosis

被引：0
|
作者：
Emsley, R. [1 ]
Schreiner, A. [2 ]
Koen, L. [1 ]
Oosthuizen, P. [1 ]
Niehaus, D. [1 ]
Rabinowitz, J. [3 ]
机构：
[1] Univ Stellenbosch, ZA-7505 Tygerberg, South Africa
[2] Janssen Cilag EMEA, Beerse, Belgium
[3] Bar Ilan Univ, Ramat Gan, Israel
来源：
EARLY INTERVENTION IN PSYCHIATRY | 2008年 / 2卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：A100 / A100
页数：1
相关论文
共 50 条
  • [1] Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis - A preliminary study
    Emsley, Robin
    Medori, Rossella
    Koen, Liezl
    Osthuizen, Petrus Paulus
    Niehaus, Dana J. H.
    Rabinowitz, Jonathan
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (02) : 210 - 213
  • [2] Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres: An Open-Label, Randomized Controlled Trial
    Covell, Nancy H.
    McEvoy, Joseph P.
    Schooler, Nina R.
    Stroup, T. Scott
    Jackson, Carlos T.
    Rojas, Ingrid A.
    Essock, Susan M.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (05) : 669 - 675
  • [3] Treatment of schizophrenia with long-acting injectable risperidone: A 12-month open-label trial of the first long-acting second-generation antipsychotic
    Fleischhacker, WW
    Eerdekens, M
    Karcher, K
    Remington, G
    Llorca, PM
    Chrzanowski, W
    Martin, S
    Gefvert, O
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (10) : 1250 - 1257
  • [4] An open-label randomized trial comparing risperidone long acting injectable (RLAI) with oral antipsychotic medication in the treatment of early psychosis
    Malla, Ashok
    Chue, Pierre
    Jordan, Gerald
    Stip, Emmanuel
    Koczerginski, David
    Milliken, Heather
    Joseph, Anil
    Williams, Richard
    Adams, Beverly
    Manchanda, Rahul
    Oyewumi, Kola
    Roy, Marc-Andre
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 : 100 - 100
  • [5] Long-acting injectable risperidone in treatment refractory patients: A 14-week open-label pilot study
    Procyshyn, Ric M.
    Barr, Alasdair M.
    Flynn, Sean
    Schenk, Chris
    Ganesan, Soma
    Honer, William G.
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 123 (2-3) : 273 - 275
  • [6] EFFICACY OF LONG-ACTING INJECTABLE RISPERIDONE IN DELUSIONAL DISORDER: AN OPEN-LABEL, NATURALISTIC AND PROSPECTIVE STUDY
    Gonzalez Rodriguez, A.
    Molina Andreu, O.
    Imaz Gurrutxaga, M. L.
    Pons Villanueva, A.
    [J]. EUROPEAN PSYCHIATRY, 2012, 27
  • [7] Risperidone long-acting injectable for maintenance therapy in bipolar disorder:: An open-label pilot study
    Braeunig, Peter
    Sacchett, Emilio
    Medori, Rossella
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (01) : 74 - 77
  • [8] A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea
    Lee, Nam Young
    Kim, Se Hyun
    Cho, Seong Jin
    Chung, Young-Cho
    Jung, In Kwa
    Kim, Chang Yoon
    Kim, Duk Ho
    Lee, Dong Geun
    Lee, Yo Han
    Lim, Weon Jeong
    Na, Young Suk
    Shin, Sang Eun
    Woo, Jong-Min
    Yoon, Jin Sang
    Yoon, Bo-Hyun
    Ahn, Yong Min
    Kim, Yong Sik
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (05) : 279 - 287
  • [9] Open-label Pilot Study of Long-Acting Injectable Naltrexone Treatment for Cannabis Dependence
    Notzon, Daniel
    Kelly, Meredith
    Choi, Chien-Wen Jean
    Pavlicova, Martina
    Mahony, Amy
    Brooks, Daniel
    Mariani, John
    Levin, Frances
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2017, 26 (03): : 252 - 252
  • [10] Long-acting injectable risperidone effective treatment for first-episode psychosis
    Perkins, Carlos, Jr.
    [J]. CNS SPECTRUMS, 2006, 11 (11) : 816 - 817
12345